Walleye Trading LLC Vir Biotechnology, Inc. Put Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $183,280 - $215,591	-7,900 Reduced 41.36%	11,200 $274,000
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $425,166 - $589,235	19,100 New	19,100 $444,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $464,061 - $876,219	-21,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $538,878 - $940,122	-17,400 Reduced 44.27%	21,900 $917,000
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $1.37 Million - $2.14 Million	39,300 New	39,300 $1.71 Million
Q1 2021 May 17, 2021	SELL	$26.34 - $83.07 $136,968 - $431,963	-5,200 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $132,652 - $225,576	5,200 New	5,200 $139,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.